Neo Ivy Capital Management Adma Biologics, Inc. Transaction History
Neo Ivy Capital Management
- $294 Million
- Q3 2024
A detailed history of Neo Ivy Capital Management transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Neo Ivy Capital Management holds 48,584 shares of ADMA stock, worth $784,631. This represents 0.33% of its overall portfolio holdings.
Number of Shares
48,584Holding current value
$784,631% of portfolio
0.33%Shares
1 transactions
Others Institutions Holding ADMA
# of Institutions
316Shares Held
189MCall Options Held
917KPut Options Held
91.6K-
Black Rock Inc. New York, NY18.6MShares$301 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.1MShares$293 Million0.01% of portfolio
-
State Street Corp Boston, MA13MShares$210 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA12.6MShares$204 Million0.05% of portfolio
-
Morgan Stanley New York, NY8.6MShares$139 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.17B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...